Summary
The neuronal storage dystrophy produced experimentally by chloroquine, contains models for quite a number of well known neurological storage diseases, almost all of which can be traced back to genetically determined defects of various lysosomal enzymes. Within the nervous system the neurones of the posterior root and trigeminal ganglia are predominantly affected in the experimental disease. Electronmicroscopically one finds unusually complex and regionally differing combinations of various types of storage bodies. In rats, the perikarya of posterior root and trigeminal nerve cells contained predominantly the concentrically layered type of membranous cytoplasmic bodies (MCBs) such as seen in infantile amaurotic idiocy. In rabbits, on the other hand, the majority of MCBs consisted of the “zebra body” type, as seen especially in gargoylism. Within the frequent axonal balloonings of these cells there are, in both species, additional small to very large accumulations of glycogen granules or particles usually surrounded by one or several membranes; in type II glycogenosis such glycogen deposits are also stored within neurones. Storage bodies with extensive curvilinear segments are found exclusively within the affected perikarya of neurones in the trigeminal ganglia of rats; they lay either massed together or scattered amongst the layered MCBs. Similar cytosomes are found in some forms of neuronal ceroid-lipofuscinosis.
Thin layer chromatography of lipid extracts showed an unequivocal increase of a substance with theR F-value between gangliosideG D1a andG D1b in materials derived from spinal ganglia of four of our experimental rabbits. An increase of phospholipids within the storage areas of neurones of posterior root ganglia was, so far, only suggested by the histochemical test with acid hematein.
The number of cytoplasmic granules with intensive yellow fluorescence within the pyramidal cells of the cornu ammonis was considerably increased. However only a small proportion of these granules could be related to layered MCBs; moreover MCBs within this location often differed in origin from the type observed in nerve cells of the sensory ganglia. Likewise the axonal dystrophy of neurones within the central nervous system differed already under the light microscope from comparable changes in cells of the posterior root and trigeminal ganglia.
The vacuoles present in the “red myopathy” were due principally to a phospholipidosis. At the same time there was a selective evenly disseminated glycogenosis of the affected type I muscle fibres as seen in Pompe's disease in all fibre types. In young rats there was relatively little degeneration of the type I muscle fibres, however these fibres showed a greatly increased activity of phosphorylase which even exeeded that found in the type II fibres. This may be a consenquence of the glycogenosis.
The distal chloroquine neuropathy was accentuated in those muscles which showed the greatest lesions. It consisted, in the main, of myelin breakdown which never reached the state of neutral fat. The myopathy was not neurogenic. In man its unusual localization and progression is likewise explained by the predominant affection of the red muscle fibres.
Almost all the histological changes noted within the nervous and muscular system could be explained through a molecular interaction between phospholipids and chloroquine due to the amphiphilic character of the drug and through the accumulation of the drug in lysosomes and an impairment in their digestive capacity.
Article PDF
Avoid common mistakes on your manuscript.
Literatur
Abraham, R., Hendy, R., Grasso, S.: Formation of myeloid bodies in rat liver lysosomes after chloroquine administration. Exp. molec. Path.9, 212–229 (1968)
Abraham, R., Hendy, R.: Irreversible lysosomal damage induced by chloroquine in the retinae of pigmented and albino rats. Exp. molec. Path.12, 185–200 (1970)
Abraham, R., Hendy, R.: Effects of chronic chloroquine treatment on lysosomes of rat liver cells. Exp. molec. Path.12, 148 (1970)
Allison, A. C.: Effects of drugs and toxic agents on lysosomes. In: The interaction of drugs and subcellular components in animal cells. London: P. N. Campbell 1968
Allison, A. C., Young, M. R.: Uptake of dyes and drugs by living cells in culture. Life Sci.3, 1407–1414 (1964)
Arai, K., Yates, R. D., Rappoport, D. A.: Fine structure and chemical composition of opaque cytoplasmic bodies of triparanol treated Syrian hamsters. II. Phospholipid analysis of opaque bodies from adrenal glands. Tex. Rep. Biol. Med.,25, 350–359 (1967)
Begg, T. B., Simpson, J. A.: Chloroquine “neuromyopathy”. Brit. med. J.1964 I, 770
Bernstein, H., Zvaifler, N., Rubin, M., Sister Mansour, A. M.: The ocular deposition of chloroquine. Invest. Ophthal.2, 384–392 (1963)
Blom, S., Lundberg, P. O.: Reversible myopathy in chloroquine treatment. Acta med. scand.177, 685–688 (1965)
Brock, N., Wilk, W.: Zur Ernährung der Laboratoriumstiere. 1. Mitteilung: Altromin® —eine Standard-Diät für Ratte und Maus. Arzneimittelforsch.11, 1071–1086 (1961)
Buksowicz, C., Dowzenko, A., Dymecki, J.: Chloroquine neuromyopathy. Polish med. J.4, 839–842 (1965)
Chapman, R. S., Ewen, W. B.: Chloroquine-induced myopathy. Brit. J. Derm.81, 217–219 (1969)
Ciak, J., Hahn, F. E.: Chloroquine: mode of action. Science151, 347–349 (1966)
Citoler, P., Beniter, L., Maurer, W.: Autoradiographische Untersuchung der Protein-Synthese in roten und weißen Muskelfasern Exp. Cell Res.45, 195–205 (1967)
Clément, R., Gruner, J., Rameix, P., Bretagne, J.: Idiotie amaurotique de Tay-Sachs. Presse méd.61, 253–255 (1953)
De Duve, C.: Lysosomes as targets for drugs. In: The interaction of drugs and subcellular components in animal cells. London: P. N. Campbell 1968
Eadie, M. J., Ferrier, T. M.: Chloroquine myopathy. J. Neurol. Neurosurg. Psychiat.29 331–337 (1966)
Engel, A. G.: Acid maltase deficiency in adults: Studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain93, 599–616 (1970)
Fardeau, M., Godet-Guillain, J.: Étude ultrastructurale des plaques motrices du muscle squelettique humain et de leurs modifications pathologiques. Proc. VIth Internat. Congr. Neuropath., Paris 1970
Gambetti, P., Di Mauro, S., Baker, L.: Nervous system in Pompe's disease. J. Neuropath. exp. Neurol.30, 412–430 (1971)
Garcin, R., Rondot, P., Fardeau, M.: Sur les accidents neuromusculaires et en particulier sur une “myopathie vacuolaire” observés au cours d'un traitement prolongé par le chloroquine. Rev. neurol.111, 177–195 (1964)
Gleiser, C. A., Bay, W. W., Dukes, T. W., Brown, R. S., Read, W. K., Pierce, K. R.: Study on chloroquine toxicity and a drug-induced cerebrospinal, lipodystrophy in swine. Amer. J. Path.53, 27–45 (1968)
Grundmann, M., Mikulikova, I., Vrublovsky, P.: Tissue distribution of chloroquine in rats in the course of long-term application. Arch. int. Pharmacodyn.197, 45–52 (1972)
Hendy, R. J., Abraham, R., Grasso, P.: The effect of chloroquine on rat heart lysosomes. J. Ultrastruct. Res.29, 485–495 (1969)
Hicklin, J. A.: Chloroquine neuromyopath. Ann. Phys. Med.9, 189–192 (1968)
Hughes, J. T., Esiri, M., Oxbury, J. M., Whitty, C. W. M.: Chloroquine myopathy. Quart. J. Med.40, 85–93 (1971)
Itabashi, H. H., Kökmen, E.: Chloroquine neuromyopathy. Arch. Path.93, 209–218 (1972)
Jatzkewitz, H.: Zerebrale Sphingolopidosen als angeborene Stoffwechselstörungen. Dtsch. med. Wschr.95, 131–139 (1970)
Jatzkewitz, H.: Briefliche Mitteilung (1972)
Klinghardt, G. W.: Histopathologische Besonderheiten der Myoneuropathie durch Chlorochindiphosphat. Naturwissenchaften55, 136–137 (1968)
Klinghardt, G. W.: Experimentelle Untersuchungen zur Ätiologie der Polyneuropathie durch Nitrofurane und zur Histopathologie der Neuro-Myopathie durch Chlorochindiphosphat (Resorchin®). Beitr Neurochir.16, 55–61 (1970)
Klinghardt, G. W.: Histopathologie des Nervensystems bei experimenteller Chlorochin-Intoxikation. Verh. dtsch. Ges. Path.55, 840 (1971)
Klinghardt, G. W.: Experimentelle Beiträge zur Neuropathologie aktueller Pharmaka vom Chinolintyp. Zbl. ges. Neurol. Psychiat.208, 127 (1974)
Klinghardt, G. W., Thomas, E.: Experimental myoneuropathy of certain drugs of 8-amino quinoline type. Proc. VIth Internat. Congr. Neuropah., pp. 1076–1077. Paris 1970
Krücke, W.: Erkrankungen des peripheren Nervensystems. In: Hdb. d. spez. pathol. Anat. und Histol., Vol. XIII/5. Teil, S. 1–248. O. Lubarsch, F. Henke, u. R. Rössle, Hrsg. Berlin: Springer 1955
Krücke, W.: Histologie der Polyneuritis und Polyneuropathe. Dtsch. Z. Nervenheilk.180, 1–39 (1959)
Krücke, W., Önol, B.: Zur Histopathologie der peripheren Neurone bei amaurotischer Idiotie. Zbl. ges. Neurol. Psychiat.191, 133 (1968)
Leading article: Chloroquine neuromyopathy. Brit. med. J.1964 I, 452
Loftus, L. R.: Peripheral neuropathy following chloroquine therapy. Canad. med. Ass. J.89, 917–920 (1963)
Lüllmann, H., Lüllmann-Rauch, R., Wassermann, O.: Arzneimittel-induzierte Phospholipid-speicherkrankheit. Dtsch. med. Wschr.,98, 1616–1625 (1973)
MacDonald, R. D., Engel, A. G.: Experimental chloroquine myopathy. J. Neuropath. exp. Neurol.29, 479–499 (1970)
Martin, J. J., de Barsy, Th., van Hoof, F., Palladini, G.: Pompe's disease: An inbornt lysosomal disorder with storage of glycogen. Acta neuropath. (Berl.)23, 229–244 (1973)
Miller, W. S., Smith, J. G.: Effect of acetylsalicylic acid on lysosomes. Proc. Soc. exp. Biol. (N.Y.)122, 634–636 (1966)
Millingen, K. S., Suerth, E.: Peripheral neuromyopathy following chloroquine therapy. Med. J. Aust.1, 840–841 (1966)
Olsson, Y.: Studies on vascular permeability in peripheral nerves. IV. Distribution of intravenously injected protein tracers in the peripheral nervous system in various species. Acta neuropath. (Berl.)17, 114–126 (1971)
Read, W. K., Bay, W. W.: Basic cellular lesion in chloroquine toxicity. Lab. Invest.24, 246–259 (1971)
Reichel, W., Hollander, J., Clark, J. H., Strehler, B. L.: Lipofuscin pigment accumulation as a function of age and distribution in rodent brain. J. Geront.23, 71–78 (1968)
Rewcastle, N. B., Humphrey, J. G.: Vacuolar myopathy: Clinical, histochemical and microscopic study. Arch. Neurol. (Chic.)12, 570–582 (1965)
Rouser, G., Kritschevsky, G., Yamamoto, A. G., Knudson, J., Simon, G.: Lipids3, 287 (1968)
Rubin, M., Zvaifler, N., Bernstein, H., Mansour, A.: Chloroquine toxicity. Proc. 2nd Internat. Pharm. Meet., Prague 1963, Vol IV, pp. 467–486. Oxford 1965
Sandhoff, K.: Briefliche Mitteilung (1974)
Sandhoff, K., Jatzkewitz, H., Peters, G.: Die infantile amaurotische Idiotie und verwandte Formen von Gangliosid-Speicherkrankheiten. Naturwissenschaften56, 356–362 (1969)
Seitelberger, F.: Neuropathological conditions related to neuroaxonal dystrophy. Acta neuropath. (Berl.), Suppl. V, 17–29 (1971)
Smith, B., O'Grady, G.: Experimental chloroquine myopathy. Neurol. Neurosurg. Psychiat.29, 255–258 (1966)
Stern, J.: The induction of ganglioside storage in nervous system cultures. Lab. Invest.26, 509–514 (1972)
Svennerholm, L.: Chromatographic separation of human brain gangliosides. J. Neurochem.10, 613–623 (1963)
Terry, D. D.: Electron microscopy of selected neurolipidoses. Handbook of clinical neurology, P. J. Vinken and G. W. Bruyn, Eds., Vol. X, pp. 362–384. Amsterdam 1970
Tischner, K. H.: Chloroquine-induced alterations in rat sensory ganglia cultivated in vitro. Acta neuropath. (Berl.)22, 208–221 (1972)
Venable, J. H., Coggeshall, R.: A simplified lead citrat stain for use in electron microscopy. J. Cell Biol.25 I, 407–408 (1965)
Volk, W. B., Wallace, B. J., Aronson, S. M.: Some ultrastructural and histochemical aspects of lipidoses. Cerebral lipidoses, Vol II, pp. 86–103. A. N. Vicente, P. Dustin, and A. Lowenthal, Eds. Bruxelles: Presses Academiques Européennes 1968
Waksman, B. H.: Experimental study of diphtheric polyneuritis in the rabbit and guinea pig. J. Neuropath. exp. Neurol.20, 35–77 (1961)
Wallace, B. J., Volk, B. W., Lazarus, S. S.: Fine structural localization of acid phosphatase activity in neurons of Tay-Sachs disease. J. Neuropath. exp. Neurol.23, 676 (1964)
Wallace, B. J., Volk, B. W., Schneck, L., Kaplan, H.: Fine structural localization of two hydrolytic enzymes in the cerebellum of children with lipidoses. J. Neuropath. exp. Neurol.25, 76–96 (1966)
Weber, M., Brichet, B., Ponin, F., Huriet, C., Tridon, P.: Electromyographie et neuromyopathie chloroquinique. Rev. neurol.118, 556–459 (1968)
Weissmann, G.: Labilization and stabilization of lysosomes. Fed. Proc.23, 1038–1044 (1964)
Weissmann, G.: Lysosomes. New Engl. J. Med.1965, 1084–1090, 1143–1149
Weissmann, G.: Lysosomes and joint disease. Arthr. and Rheum.9, 834–840 (1968)
Weissmann, G.: The effects of steroids and drugs on lysosomes. In: Lysosomes in biology and pathology, Vol. I, pp. 276–295. J. T. Dingle and H. B. Fell, Eds. Amsterdam: North-Holland Publ. Comp. 1969
Whisnant, J. P., Espinosa, R. E., Kierland, R. R., Lambert, E. H.: Chloroquine neuromyopathy. Proc. Mayo Clin.38, 501–513 (1963)
Yamamoto, A., Adachi, S., Ishibe, T., Shinji, Y., Kaki-Uchi, Y., Seki, K., Seki, K., Kitani, T.: Accumulation of acid phospholipids in a case of hyperlipidemia with hepatosplenomegaly. Lipids5, 566–571 (1970)
Yamamoto, A., Adachi, S., Kitani, T., Shinji, Y., Seki, K., Nasu, T., Nishikawa, M.: Drug induced lipidosis in human cases and in animal experiments. J. Biochem.69, 613–615 (1971)
Yu, M. C., Bakay, J., Lee, J. C.: Ultrastructure of the central nervous system after prolonged hypoxia. Acta neuropath. (Berl.)22, 222–234 (1972)
Zvaifler, N. J., Rubin, M.: The metabolism of chloroquine. Arthr. and Rheum.5, 330 (1962)
Author information
Authors and Affiliations
Additional information
Mit Unterstützung der Deutschen Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Klinghardt, G.W. Experimentelle Schädigungen von Nervensystem und Muskulatur durch Chlorochin: Modelle verschiedenartiger Speicherdystrophien. Acta Neuropathol 28, 117–141 (1974). https://doi.org/10.1007/BF00710322
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00710322